Dr. Amy Coxon is a biologist and lab manager for the Brownell Lab. She has received awards for her research including the American Association for Cancer Research (AACR)-AFLAC Young Investigators Award and the American Association for Cancer Research-Pharmingen Young Investigators Awards. She has presented at meetings such as the AACR Mouse Models of Cancer Meeting, the AACR meetings, and the Oncogenes and Tumors Suppressor meetings. In addition, she received an NIH Office of the Director Honor Award for her work in transferring critical cell lines to a National Cancer Institute cell line repository.
Dr. Coxon worked on lung cancer, developed a model for medullary thyroid cancer that mimicked human MEN2A mutations, and studied a translocation involved in the development of salivary gland cancer, before coming to work in the Brownell Lab. In the Brownell Lab, she is involved in the study of merkel cell carcinoma (MCC), a rare and aggressive skin cancer. She also investigates the Merkel cell polyomavirus that drives MCC. Dr. Coxon applies her expertise in molecular biology, mouse genetics, and xenograft models to investigate the pathobiology of MCC with the goal of identifying novel therapeutic targets.